NM-01 is a novel technetium-99m SPECT imaging agent currently being developed for the assessment of PD-L1 expression in cancer cells
NORTH BILLERICA, Mass., May 13, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc.
Lantheus Holdings, Inc. (“the Company”) (NASDAQ:LNTH), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence
Lantheus Holdings (NASDAQ:LNTH) reported its Q1 earnings results on Friday, April 29, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Lantheus Holdings (NASDAQ:LNTH) reported quarterly earnings of $0.97 per share which beat the analyst consensus estimate of $0.46 by 110.87 percent. This is a 1840 percent increase over earnings of $0.05 per share from
Lantheus Holdings (NASDAQ:LNTH) is set to give its latest quarterly earnings report on Friday, 2022-04-29. Here's what investors need to know before the announcement.
Analysts estimate that Lantheus Holdings will report an earnings per share (EPS) of $0.46.